GlaxoSmithKline Plc, fined last year in a Chinese government investigation, has rehired Vivian Shi, who left her post as a Shanghai-based government affairs executive in 2012, before the scandal.
“We can confirm we have rehired Vivian,” Glaxo said in an e-mailed statement. “We are not going to comment further on an individual employee.”
Shi wasn’t available for comment, Glaxo said, and efforts to reach her were unsuccessful.
Glaxo was fined 3 billion yuan ($483 million) by the Chinese government last year after being found guilty of bribing non-government personnel. The company issued a public apology to the government and the Chinese people, pledging to “establish itself as a model for reform” in the country’s health-care industry.
Last year, Shi was mentioned in several U.K. media reports as the person a private investigator hired by Glaxo looked into as a possible source of anonymous emails to Glaxo alleging it engaged in bribery in China. In some of those reports, she is said to have denied the allegations. Glaxo said in a July 3, 2014, statement that its China unit hired the investigator to probe into a security breach linked to its then China head, not to investigate whistle blower allegations.
— With assistance by Hui Li, and Oliver Staley